Published in J Biol Chem on October 18, 2000
A new antibiotic kills pathogens without detectable resistance. Nature (2015) 6.33
Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria. Microbiol Mol Biol Rev (2006) 4.88
Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob Agents Chemother (2009) 2.83
Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds. Nat Prod Rep (2009) 2.32
Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob Agents Chemother (2007) 2.27
The SapB morphogen is a lantibiotic-like peptide derived from the product of the developmental gene ramS in Streptomyces coelicolor. Proc Natl Acad Sci U S A (2004) 2.04
Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci U S A (2007) 1.81
Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol (2009) 1.68
Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol (2008) 1.60
Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB. Nature (2014) 1.53
The LiaFSR system regulates the cell envelope stress response in Streptococcus mutans. J Bacteriol (2009) 1.50
Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl Environ Microbiol (2007) 1.46
The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob Agents Chemother (2002) 1.41
The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob Agents Chemother (2009) 1.38
Purification and characterization of streptin, a type A1 lantibiotic produced by Streptococcus pyogenes. Appl Environ Microbiol (2003) 1.38
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother (2006) 1.36
Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl Environ Microbiol (2006) 1.35
Nisin-induced changes in Bacillus morphology suggest a paradigm of antibiotic action. Proc Natl Acad Sci U S A (2006) 1.30
Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother (2005) 1.30
Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules. Proc Natl Acad Sci U S A (2013) 1.24
The dual role of bacteriocins as anti- and probiotics. Appl Microbiol Biotechnol (2008) 1.22
Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II. J Biol Chem (2010) 1.19
Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob Agents Chemother (2006) 1.19
Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J Bacteriol (2004) 1.17
Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR. Antimicrob Agents Chemother (2009) 1.17
The par toxin-antitoxin system from Enterococcus faecalis plasmid pAD1 and its chromosomal homologs. RNA Biol (2012) 1.17
Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One (2009) 1.14
Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V. Microb Biotechnol (2010) 1.14
The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcuspneumoniae. Proc Natl Acad Sci U S A (2002) 1.12
Phosphoinositide-mediated oligomerization of a defensin induces cell lysis. Elife (2014) 1.11
Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate. Chem Biol (2011) 1.10
Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob Agents Chemother (2009) 1.10
Immunity to the bacteriocin sublancin 168 Is determined by the SunI (YolF) protein of Bacillus subtilis. Antimicrob Agents Chemother (2008) 1.09
Nisin adsorption to hydrophobic surfaces coated with the PEO-PPO-PEO triblock surfactant Pluronic F108. J Colloid Interface Sci (2008) 1.09
Inhibition of Bacillus anthracis spore outgrowth by nisin. Antimicrob Agents Chemother (2008) 1.08
Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5. Appl Environ Microbiol (2004) 1.07
Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. ACS Chem Biol (2011) 1.06
Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus. PLoS Pathog (2012) 1.06
Nisin antimicrobial activity and structural characteristics at hydrophobic surfaces coated with the PEO-PPO-PEO triblock surfactant Pluronic F108. J Colloid Interface Sci (2008) 1.02
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol (2006) 1.01
Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation. Proc Natl Acad Sci U S A (2002) 0.98
Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II. PLoS Pathog (2013) 0.97
Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis. J Biol Chem (2014) 0.96
Specific interaction of the unmodified bacteriocin Lactococcin 972 with the cell wall precursor lipid II. Appl Environ Microbiol (2008) 0.96
Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. J Immunol (2011) 0.95
The maltose ABC transporter in Lactococcus lactis facilitates high-level sensitivity to the circular bacteriocin garvicin ML. Antimicrob Agents Chemother (2012) 0.95
Detection of nisin and fibrinogen adsorption on poly(ethylene oxide) coated polyurethane surfaces by time-of-flight secondary ion mass spectrometry (TOF-SIMS). J Colloid Interface Sci (2011) 0.94
Variations in the degree of D-Alanylation of teichoic acids in Lactococcus lactis alter resistance to cationic antimicrobials but have no effect on bacterial surface hydrophobicity and charge. Appl Environ Microbiol (2008) 0.93
The large mechanosensitive channel MscL determines bacterial susceptibility to the bacteriocin sublancin 168. Antimicrob Agents Chemother (2009) 0.93
Mechanistic dissection of the enzyme complexes involved in biosynthesis of lacticin 3147 and nisin. Appl Environ Microbiol (2008) 0.93
Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1. Appl Environ Microbiol (2006) 0.93
Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity. PLoS One (2013) 0.92
Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.92
Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med (2012) 0.92
The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. BMC Microbiol (2008) 0.92
Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5. Antimicrob Agents Chemother (2011) 0.91
Screen for inhibitors of the coupled transglycosylase-transpeptidase of peptidoglycan biosynthesis in Escherichia coli. Antimicrob Agents Chemother (2006) 0.90
The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity. Front Microbiol (2015) 0.90
A Zn-dependent metallopeptidase is responsible for sensitivity to LsbB, a class II leaderless bacteriocin of Lactococcus lactis subsp. lactis BGMN1-5. J Bacteriol (2013) 0.89
The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions. J Biol Chem (2014) 0.89
Enhanced production, purification, characterization and mechanism of action of salivaricin 9 lantibiotic produced by Streptococcus salivarius NU10. PLoS One (2013) 0.89
Lantibiotic resistance. Microbiol Mol Biol Rev (2015) 0.89
Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob Agents Chemother (2009) 0.89
Characterization of a regulatory network of peptide antibiotic detoxification modules in Lactobacillus casei BL23. Appl Environ Microbiol (2013) 0.88
C-terminal amino acids of alpha-melanocyte-stimulating hormone are requisite for its antibacterial activity against Staphylococcus aureus. Antimicrob Agents Chemother (2011) 0.88
Nisin ZP, a Bacteriocin and Food Preservative, Inhibits Head and Neck Cancer Tumorigenesis and Prolongs Survival. PLoS One (2015) 0.88
Circumventing the effect of product toxicity: development of a novel two-stage production process for the lantibiotic gallidermin. Appl Environ Microbiol (2006) 0.87
Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl Environ Microbiol (2002) 0.87
Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors. Appl Environ Microbiol (2008) 0.87
Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147. Microb Biotechnol (2009) 0.86
Physical and antibiotic stresses require activation of the RsbU phosphatase to induce the general stress response in Listeria monocytogenes. Microbiology (2010) 0.86
Bioengineering Lantibiotics for Therapeutic Success. Front Microbiol (2015) 0.86
Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection. PLoS One (2014) 0.85
Peptides and Peptidomimetics for Antimicrobial Drug Design. Pharmaceuticals (Basel) (2015) 0.85
Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives. PLoS One (2013) 0.85
Three distinct two-component systems are involved in resistance to the class I bacteriocins, Nukacin ISK-1 and nisin A, in Staphylococcus aureus. PLoS One (2013) 0.85
Novel LanT associated lantibiotic clusters identified by genome database mining. PLoS One (2014) 0.85
A crystal structure of a dimer of the antibiotic ramoplanin illustrates membrane positioning and a potential Lipid II docking interface. Proc Natl Acad Sci U S A (2009) 0.85
Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity. BMC Microbiol (2007) 0.84
In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model. Antimicrob Agents Chemother (2014) 0.84
Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X. J Am Chem Soc (2012) 0.84
Probiotic therapy - recruiting old friends to fight new foes. Gut Pathog (2010) 0.84
Easy and rapid purification of highly active nisin. Int J Pept (2011) 0.84
Antibacterial activities of nisin Z encapsulated in liposomes or produced in situ by mixed culture during cheddar cheese ripening. Appl Environ Microbiol (2002) 0.83
Quantifying nisin adsorption behavior at pendant PEO layers. J Colloid Interface Sci (2013) 0.83
Circular bacteriocins: biosynthesis and mode of action. Appl Environ Microbiol (2014) 0.83
Synergistic activity and mechanism of action of Stephania suberosa Forman extract and ampicillin combination against ampicillin-resistant Staphylococcus aureus. J Biomed Sci (2014) 0.83
Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P. Appl Environ Microbiol (2010) 0.83
Bioengineering of the model lantibiotic nisin. Bioengineered (2015) 0.82
Investigating the importance of charged residues in lantibiotics. Bioeng Bugs (2011) 0.82
The bacterial peptide pheromone plantaricin A permeabilizes cancerous, but not normal, rat pituitary cells and differentiates between the outer and inner membrane leaflet. J Membr Biol (2007) 0.82
Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms. Antonie Van Leeuwenhoek (2014) 0.82
In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice. BMC Microbiol (2013) 0.82
Defining intact protein primary structures from saliva: a step toward the human proteome project. Anal Chem (2012) 0.82
A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides. BMC Microbiol (2010) 0.81
Antimicrobial peptides: their role as infection-selective tracers for molecular imaging. Biomed Res Int (2014) 0.81
Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium. Nat Commun (2016) 0.81
Engineering of Bacillus subtilis 168 for increased nisin resistance. Appl Environ Microbiol (2009) 0.81
Lantibiotic immunity: inhibition of nisin mediated pore formation by NisI. PLoS One (2014) 0.81
The virucidal EB peptide protects host cells from herpes simplex virus type 1 infection in the presence of serum albumin and aggregates proteins in a detergent-like manner. Antimicrob Agents Chemother (2010) 0.81
Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol (1996) 7.12
Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta (1979) 5.39
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science (1999) 5.30
Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria. Mol Microbiol (1997) 4.28
Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother (1985) 3.83
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol (2009) 3.45
Functional analysis of promoters in the nisin gene cluster of Lactococcus lactis. J Bacteriol (1996) 3.23
Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu Rev Microbiol (1998) 3.04
Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes. Biochim Biophys Acta (1974) 2.79
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69
Different membrane anchoring positions of tryptophan and lysine in synthetic transmembrane alpha-helical peptides. J Biol Chem (1999) 2.44
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur J Biochem (1995) 2.37
Controlled gene expression systems for lactic acid bacteria: transferable nisin-inducible expression cassettes for Lactococcus, Leuconostoc, and Lactobacillus spp. Appl Environ Microbiol (1997) 2.27
Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. I. Specificity of the membrane permeability changes induced by the polyene antibiotics. Biochim Biophys Acta (1974) 2.25
Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. J Gen Microbiol (1981) 2.20
Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol Life Sci (2008) 2.18
Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by gram-positive bacteria. Mol Microbiol (1995) 2.15
Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes. J Bacteriol (1988) 2.10
Improved methods to isolate and subfractionate rat liver mitochondria. Lipid composition of the inner and outer membrane. Biochim Biophys Acta (1990) 2.10
Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry (1995) 2.10
The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother (1998) 2.06
Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl Environ Microbiol (1998) 1.96
Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes. FEBS Lett (1989) 1.95
Visualizing detergent resistant domains in model membranes with atomic force microscopy. FEBS Lett (2001) 1.92
Efficient random mutagenesis method with adjustable mutation frequency by use of PCR and dITP. Nucleic Acids Res (1993) 1.89
Comparison of lantibiotic gene clusters and encoded proteins. Antonie Van Leeuwenhoek (1996) 1.88
Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis (1999) 1.87
Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85
Comparative studies on the effects of pH and Ca2+ on bilayers of various negatively charged phospholipids and their mixtures with phosphatidylcholine. Biochim Biophys Acta (1978) 1.83
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol (1987) 1.82
Influence of amino acid substitutions in the nisin leader peptide on biosynthesis and secretion of nisin by Lactococcus lactis. J Biol Chem (1994) 1.82
Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl Environ Microbiol (2000) 1.81
Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch Microbiol (1985) 1.81
Transcriptional activation of the glycolytic las operon and catabolite repression of the gal operon in Lactococcus lactis are mediated by the catabolite control protein CcpA. Mol Microbiol (1998) 1.79
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
Anionic phospholipids are determinants of membrane protein topology. EMBO J (1997) 1.77
Food-grade controlled lysis of Lactococcus lactis for accelerated cheese ripening. Nat Biotechnol (1997) 1.74
The polymorphic phase behaviour of phosphatidylethanolamines of natural and synthetic origin. A 31P NMR study. Biochim Biophys Acta (1978) 1.73
Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol (1996) 1.71
Phosphatidylglycerol is involved in protein translocation across Escherichia coli inner membranes. Nature (1988) 1.71
Influence of the staphylococcinlike peptide Pep 5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles. J Bacteriol (1985) 1.71
Negatively charged phospholipids restore prePhoE translocation across phosphatidylglycerol-depleted Escherichia coli inner membranes. J Biol Chem (1991) 1.70
Properties of nisin Z and distribution of its gene, nisZ, in Lactococcus lactis. Appl Environ Microbiol (1993) 1.68
Freeze-etch electron microscopy of erythrocytes, Acholeplasma laidlawii cells and liposomal membranes after the action of filipin and amphotericin B. Biochim Biophys Acta (1973) 1.68
The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry (1997) 1.66
Sensitivity of single membrane-spanning alpha-helical peptides to hydrophobic mismatch with a lipid bilayer: effects on backbone structure, orientation, and extent of membrane incorporation. Biochemistry (2001) 1.64
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem (1997) 1.59
Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 1.58
Biomembranes. Lipids beyond the bilayer. Nature (1997) 1.58
Structure, organization, and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis. J Biol Chem (1993) 1.58
Anionic phospholipids are involved in membrane association of FtsY and stimulate its GTPase activity. EMBO J (2000) 1.56
The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur J Biochem (1989) 1.54
Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54
Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob Agents Chemother (1995) 1.52
SecA insertion into phospholipids is stimulated by negatively charged lipids and inhibited by ATP: a monolayer study. Biochemistry (1992) 1.52
The influence of dolichol, dolichol esters, and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes. J Biol Chem (1985) 1.52
Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur J Biochem (1995) 1.50
Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin. Antimicrob Agents Chemother (1985) 1.48
Cytochrome c specifically induces non-bilayer structures in cardiolipin-containing model membranes. Biochim Biophys Acta (1980) 1.47
Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl Environ Microbiol (1995) 1.45
Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. A monolayer study. Eur J Biochem (1996) 1.42
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Phospholipid Motional Characteristics in a Dry Biological System : A P-Nuclear Magnetic Resonance Study of Hydrating Typha latifolia Pollen. Plant Physiol (1982) 1.40
Polyene antibiotic-sterol interactions in membranes of Acholesplasma laidlawii cells and lecithin liposomes. II. Temperature dependence of the polyene antibiotic-sterol complex formation. Biochim Biophys Acta (1974) 1.39
The C terminus of SecA is involved in both lipid binding and SecB binding. J Biol Chem (1995) 1.38
Non-bilayer lipids are required for efficient protein transport across the plasma membrane of Escherichia coli. EMBO J (1995) 1.36
Single cell analysis of gene expression patterns of competence development and initiation of sporulation in Bacillus subtilis grown on chemically defined media. J Appl Microbiol (2006) 1.31
Dynamin is membrane-active: lipid insertion is induced by phosphoinositides and phosphatidic acid. Biochemistry (2000) 1.31
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem (1999) 1.29
Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane? Biochim Biophys Acta (1997) 1.28
Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol (1998) 1.28
Molecular basis of glycoalkaloid induced membrane disruption. Biochim Biophys Acta (1995) 1.28
Posttranslationally modified bacteriocins--the lantibiotics. Biopolymers (2000) 1.27
Lactic acid bacteria: the bugs of the new millennium. Curr Opin Microbiol (2000) 1.25
Characterization of a locus from Carnobacterium piscicola LV17B involved in bacteriocin production and immunity: evidence for global inducer-mediated transcriptional regulation. J Bacteriol (1997) 1.24
Visualization of highly ordered striated domains induced by transmembrane peptides in supported phosphatidylcholine bilayers. Biochemistry (2000) 1.24
Immunity to lantibiotics. Antonie Van Leeuwenhoek (1996) 1.24
The orientation of nisin in membranes. Biochemistry (1998) 1.23
X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor. Nature (1990) 1.23
The lantibiotic nisin, a special case or not? Biochim Biophys Acta (1999) 1.23
Characterisation of new intracellular membranes in Escherichia coli accompanying large scale over-production of the b subunit of F(1)F(o) ATP synthase. FEBS Lett (2000) 1.23
Functional domains of the ferredoxin transit sequence involved in chloroplast import. J Biol Chem (1995) 1.23